```

[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[S. 1094 Enrolled Bill (ENR)]

        S.1094

                      One Hundred Seventh Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

         Begun and held at the City of Washington on Wednesday,
          the twenty-third day of January, two thousand and two

                                 An Act

 
    To amend the Public Health Service Act to provide for research, 
        information, and education with respect to blood cancer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hematological Cancer Research 
Investment and Education Act of 2002''.

SEC. 2. FINDINGS.

    Congress finds that:
        (1) An estimated 109,500 people in the United States will be 
    diagnosed with leukemia, lymphoma, and multiple myeloma in 2001.
        (2) New cases of the blood cancers described in paragraph (1) 
    account for 8.6 percent of new cancer cases.
        (3) Those devastating blood cancers will cause the deaths of an 
    estimated 60,300 persons in the United States in 2001. Every 9 
    minutes, a person in the United States dies from leukemia, 
    lymphoma, or multiple myeloma.
        (4) While less than 5 percent of Federal funds for cancer 
    research are spent on those blood cancers, those blood cancers 
    cause 11 percent of all cancer deaths in the United States.
        (5) Increased Federal support of research into leukemia, 
    lymphoma, and multiple myeloma has resulted and will continue to 
    result in significant advances in the treatment, and ultimately the 
    cure, of those blood cancers as well as other cancers.
SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
CANCER.
    Part C of title IV of the Public Health Service Act (42 U.S.C. 285 
et seq.) is amended by inserting after section 419C the following:
``SEC. 417D. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
CANCER.
    ``(a) Joe Moakley Research Excellence Program.--
        ``(1) In general.--The Director of NIH shall expand, intensify, 
    and coordinate programs for the conduct and support of research 
    with respect to blood cancer, and particularly with respect to 
    leukemia, lymphoma, and multiple myeloma.
        ``(2) Administration.--The Director of NIH shall carry out this 
    subsection through the Director of the National Cancer Institute 
    and in collaboration with any other agencies that the Director 
    determines to be appropriate.
        ``(3) Authorization of appropriations.--For the purpose of 
    carrying out this subsection, there is authorized to be 
    appropriated such sums as may be necessary for fiscal year 2002 and 
    each subsequent fiscal year. Such authorizations of appropriations 
    are in addition to other authorizations of appropriations that are 
    available for such purpose.
    ``(b) Geraldine Ferraro Cancer Education Program.--
        ``(1) In general.--The Secretary shall direct the appropriate 
    agency within the Department of Health and Human Services, in 
    collaboration with the Director of NIH, to establish and carry out 
    a program to provide information and education for patients and the 
    general public with respect to blood cancer, and particularly with 
    respect to the treatment of leukemia, lymphoma, and multiple 
    myeloma.
        ``(2) Administration.--The Agency determined by the Secretary 
    under paragraph (1) shall carry out this subsection in 
    collaboration with private health organizations that have national 
    education and patient assistance programs on blood-related cancers.
        ``(3) Authorization of appropriations.--For the purpose of 
    carrying out this subsection, there is authorized to be 
    appropriated such sums as may be necessary for fiscal year 2002 and 
    each subsequent fiscal year. Such authorizations of appropriations 
    are in addition to other authorizations of appropriations that are 
    available for such purpose.''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```